These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1813013

  • 1. Effect of rIFN-gamma and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii.
    Benedetto N, Auriault C, Darcy F, Lando D, Watier H, Capron A.
    Eur Cytokine Netw; 1991; 2(2):107-14. PubMed ID: 1813013
    [Abstract] [Full Text] [Related]

  • 2. Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis.
    Benedetto N, Folgore A, Galdiero M, Meli R, Di Carlo R.
    Pathol Biol (Paris); 1995 May; 43(5):395-400. PubMed ID: 8532376
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-independent protective effect of recombinant IFN-gamma against acute toxoplasmosis in T cell-deficient mice.
    Suzuki Y, Joh K, Kobayashi A.
    J Immunol; 1991 Oct 15; 147(8):2728-33. PubMed ID: 1918987
    [Abstract] [Full Text] [Related]

  • 4. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice.
    Khan IA, Kasper LH.
    J Immunol; 1996 Sep 01; 157(5):2103-8. PubMed ID: 8757333
    [Abstract] [Full Text] [Related]

  • 5. In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii.
    Sharma SD, Hofflin JM, Remington JS.
    J Immunol; 1985 Dec 01; 135(6):4160-3. PubMed ID: 3877764
    [Abstract] [Full Text] [Related]

  • 6. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
    Khan IA, Matsuura T, Fonseka S, Kasper LH.
    J Immunol; 1996 Jan 15; 156(2):636-43. PubMed ID: 8543815
    [Abstract] [Full Text] [Related]

  • 7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 15; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 8. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
    Black CM, Catterall JR, Remington JS.
    J Immunol; 1987 Jan 15; 138(2):491-5. PubMed ID: 3098846
    [Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE, Young LS.
    J Immunol; 1988 May 01; 140(9):3006-13. PubMed ID: 2834450
    [Abstract] [Full Text] [Related]

  • 10. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium.
    van Dissel JT, Stikkelbroeck JJ, Michel BC, van den Barselaar MT, Leijh PC, van Furth R.
    J Immunol; 1987 Sep 01; 139(5):1673-8. PubMed ID: 2957433
    [Abstract] [Full Text] [Related]

  • 11. Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation.
    Vey N, Viens P, Fossat C, Olive D, Sainty D, Baume D, Stoppa AM, Bouabdallah R, Brandely M, Gastaut JA, Maraninchi D, Blaise D.
    Eur Cytokine Netw; 1997 Dec 01; 8(4):389-94. PubMed ID: 9459619
    [Abstract] [Full Text] [Related]

  • 12. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii.
    Kasper LH, Matsuura T, Khan IA.
    J Immunol; 1995 Nov 15; 155(10):4798-804. PubMed ID: 7594482
    [Abstract] [Full Text] [Related]

  • 13. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF, Goldwasser E, Fitch FW.
    J Immunol; 1988 Oct 15; 141(8):2635-42. PubMed ID: 2971726
    [Abstract] [Full Text] [Related]

  • 14. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
    Gajewski TF, Fitch FW.
    J Immunol; 1988 Jun 15; 140(12):4245-52. PubMed ID: 2967332
    [Abstract] [Full Text] [Related]

  • 15. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH, Vitetta ES.
    J Immunol; 1986 Nov 15; 137(10):3205-10. PubMed ID: 2945863
    [Abstract] [Full Text] [Related]

  • 16. [Effect of rmu-IFN-gamma on the splenic T cell subsets and NK cells of pregnant mice infected with Toxoplasma gondii].
    Luo FJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Apr 30; 24(2):125-8. PubMed ID: 16862911
    [Abstract] [Full Text] [Related]

  • 17. Immune responses associated with early survival after peroral infection with Toxoplasma gondii.
    McLeod R, Eisenhauer P, Mack D, Brown C, Filice G, Spitalny G.
    J Immunol; 1989 May 01; 142(9):3247-55. PubMed ID: 2496163
    [Abstract] [Full Text] [Related]

  • 18. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation.
    Deckert-Schlüter M, Rang A, Weiner D, Huang S, Wiestler OD, Hof H, Schlüter D.
    Lab Invest; 1996 Dec 01; 75(6):827-41. PubMed ID: 8973478
    [Abstract] [Full Text] [Related]

  • 19. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
    Khan IA, Casciotti L.
    J Immunol; 1999 Oct 15; 163(8):4503-9. PubMed ID: 10510393
    [Abstract] [Full Text] [Related]

  • 20. Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma.
    Gajewski TF, Joyce J, Fitch FW.
    J Immunol; 1989 Jul 01; 143(1):15-22. PubMed ID: 2525146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.